Novioscan appointed Peter van Stiphout as its new CEO. Peter has long standing technical expertise in micro-system technologies like MEMS and thin films in life-science applications. Previously he was with Cytocentrics, OnStream and Royal Philips Electronics holding various positions within R&D and product management. His expertise in micro-system technologies, such as MEMS and thin films in life-science will be of great value to Novioscan. Peter will focus on the market introduction of the NovioMini Bladder Monitor and expand the business of Novioscan Research and NovioMEMS.
Peter van Stipthout: “I am proud to be part of the enthusiastic Novioscan team and confident to bringing the innovative products to the market. Novioscan’s expertise in ultrasound and product development will yield sound products”.
Patients are increasingly empowered to take responsibility for their own health. Small, low cost, wearable sensors are needed to monitor bodily functions. Novioscan creates wearable ultrasound sensors for specialized care and monitoring. Novioscans first product is the ‘Noviomini’. It tracks bladder filling, when the bladder is nearly full the device vibrates and a warning is sent to a smartphone.
The ‘Noviomini’ will help patients with a neurogene blatter, patients with spinal cord injuries, incontinent elderly and children with potty problems.
In order to manufacture the new generation wearable ultrasound sensors, Novioscan Research is developing an Ultrasound-on-a-Chip. Ultrasound-on-a-Chip can minimize sensors and therefore offer new possibilities for innovative solutions in health care.
Novioscan is based in Nijmegen and is supported by UMC Utrecht, Pontes Medical, University Twente, Eindhoven University of Technology and Oost NV (East Netherlands Development Agency).
Meet the Novioscan team in the Holland Pavillion at MEDICA 2016 on November 14th, Messe Düsseldorf.